MAMariana Caraballo Angelli

Mariana Caraballo Angelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariana Caraballo Angelli has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short-Term Surgical Outcomes and Postoperative Safety in Octogenarian Patients Undergoing Colorectal Cancer Resection: A Comparative Cohort Study

    by Albert Garcia-Nalda, Victor Admella-Clanchet, Anna Serracant-Barrera, Mariana Caraballo-Angeli, Laura Lazaro-Garcia, Claudia Codina-Espitia, Anna Nonell-Amill, Laura Mora-Lopez

    Background: Surgical management of colorectal cancer (CRC) in elderly adults presents complex clinical challenges due to baseline multimorbidity and frailty. This study aimed to evaluate short-term surgical safety and postoperative outcomes in carefully selected octogenarian patients (≥80 years) compared with a younger cohort (n = 604) and ≥80 years (n = 138). Clinical characteristics, frailty burden evaluated using the clinician-reported IF-VIG index, surgical techniques, histopathological staging, and 30-day postoperative morbidity were evaluated. Multivariable logistic regression was performed to adjust for potential baseline confounders including ASA status, frailty, surgical approach, and tumor stage. Results: Octogenarians exhibited a significantly higher prevalence of baseline frailty (23.2%, 32/138 evaluated vs. 5.8%, 35/605 evaluated, p < 0.001) and ASA physical status grade III–IV (70.3% vs. 45.7%, p < 0.001). Surgical approaches were comparable in both groups (p = 0.560). Overall, minimally invasive surgery rates (laparoscopic and robotic) reached 92.6% in octogenarians and 95.2% in younger controls. Specifically, robotic-assisted resection was implemented at equal rates between groups (71.1% vs. 71.1%). Overall 30-day postoperative complications were comparable (≥80: 42.0% vs. II: 9.4% vs. 11.1%, p = 0.572). Among patients undergoing primary intestinal anastomosis (n = 632), anastomotic leakage (3.5% vs. 3.1%, p = 0.835) and anastomotic bleeding (9.6% vs. 9.3%, p = 0.920) showed no significant differences. Multivariable logistic regression confirmed that advanced age ≥ 80 years was not an independent predictor of overall morbidity (aOR 0.92, 95% CI 0.60–1.41, p = 0.698). Median length of hospital stay (4 days, p = 0.391), 30-day readmissions (4.4% vs. 4.3%, p = 0.979), and 30-day in-hospital mortality (0.0% vs. 0.3%, p = 0.499) were equivalent. Conclusions: Elective curative-intent CRC resection in carefully selected octogenarians managed within a multidisciplinary pathway incorporating objective frailty assessment, prehabilitation, and minimally invasive techniques yields short-term postoperative outcomes, major complication rates, and hospital stays comparable to younger counterparts. Advanced chronological age alone should not preclude surgical resection in fit or mild-to-moderately frail older adults.

  • Open Access

    Comparative Analysis of Postoperative Outcomes Between Transanal Total Mesorectal Excision (TaTME) and Robotic Total Mesorectal Excision with TTSS Anastomosis (RTME/TTSSTEO)

    by Laura Mora López, Anna Pallisera Lloveras, Albert Garcia Nalda, Mariana Caraballo Angelli, Victor Admella Clanchet, Laura Lazaro Garcia, Claudia Codina Espitia, Anna Nonell Amill, Anna Serracant Barrera

    Surgical treatment for rectal cancer has evolved to improve outcomes. To this end, we conducted a comparative study analyzing the postoperative, pathological, and oncological outcomes of two techniques for the treatment of mid- and lower rectal cancer: Transanal Total Mesorectal Excision (TaTME) and Robotic Total Mesorectal Excision with TTSS anastomosis using the TEO â platform (RTME/TTSSTEO). A total of 146 patients who underwent surgery between 2012 and 2025 at a tertiary care center were included. Both groups were comparable in baseline characteristics and staging. The robotic technique was associated with longer operative time but a lower overall complication rate and a trend toward fewer clinical suture failures. The quality of the mesorectum and the rate of R0 resections were high in both approaches. At follow-up, local recurrence was lower in the robotic group, although the duration of follow-up was shorter. The results suggest that RTME-TTSSTEO is a safe alternative and potentially superior in terms of overall morbidity and mortality compared to TaTME.

  • Open Access

    Bowel dysfunction (LARS) and quality of life after chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab, N0, M0 rectal cancer: the TAUTEM randomized clinical trial

    by Xavier Serra-Aracil, Carles Pericay, Mariana Caraballo, Jesus Badia-Closa, Thomas Golda, Esther Kreisler, Eduardo Targarona, Nerea Borda-Arrizabalaga, Angel Reina, Salvadora Delgado, et al.

    Background: Bowel dysfunction and quality of life (QoL) are key determinants of long-term outcomes after treatment for localized rectal cancer (cT2–cT3a–b, N0, M0). Total mesorectal excision (TME) provides effective oncologic control but may cause substantial functional impairment. Organ-preserving strategies combining chemoradiotherapy with local excision may improve functional outcomes, yet long-term patient-reported data remain limited. Materials and Methods: TAUTEM is a multicenter, prospective, open-label, phase 3, randomized, noninferiority trial comparing chemoradiotherapy followed by transanal endoscopic microsurgery (CRT–TEM) with standard TME in patients with T2–T3ab, N0, M0 rectal cancer. Long-term bowel function was assessed using the Low Anterior Resection Syndrome (LARS) score ≥24 months after definitive treatment. Quality of life (QoL) was evaluated using the EORTC QLQ-C30, QLQ-CR38, and the Karnofsky Performance Status at baseline and after treatment. Analyses were conducted in the modified intention-to-treat and per-protocol populations. Results: Of 173 randomized patients, 162 were included in the modified intention-to-treat analysis (81 per group). Long-term LARS assessment was available for 96 of 102 eligible patients (94%) at a median follow-up of 87.5 months. Global QoL was higher after CRT–TEM than after TME (median 83.3 vs 66.7; P = 0.02). Permanent stoma rates were lower following CRT–TEM than after TME (7.4% vs 28.4%). Major LARS occurred less frequently after CRT–TEM than after TME (7.7% vs 36.4%; P = 0.001), with higher rates of no LARS (80.8% vs 47.7%; P = 0.001). Item-level outcomes (frequency, urgency, clustering, and flatus incontinence) consistently favored CRT–TEM. Conclusions: CRT–TEM was associated with substantially less long-term bowel dysfunction and superior QoL compared with TME, together with markedly fewer permanent stomas. These findings support organ-preserving strategies for selected patients with cT2–cT3a–b, N0, M0 rectal cancer.